Send to:

Choose Destination
See comment in PubMed Commons below
Transpl Int. 2012 Apr;25(4):369-82. doi: 10.1111/j.1432-2277.2011.01426.x. Epub 2012 Jan 16.

Mesenchymal stromal cells for tissue-engineered tissue and organ replacements.

Author information

  • 1BIOAIRlab, European Center of Thoracic Research (CERT), University Hospital Careggi, Florence, Italy.


Mesenchymal stromal cells (MSCs), a rare heterogeneous subset of pluripotent stromal cells that can be easily isolated from different adult tissues, in vitro expanded and differentiated into multiple lineages, are immune privileged and, more important, display immunomodulatory capacities. Because of this, they are the preferred cell source in tissue-engineered replacements, not only in autogeneic conditions, where they do not evoke any immune response, but especially in the setting of allogeneic organ and tissue replacements. However, more preclinical and clinical studies are requested to completely understand MSC's immune biology and possible clinical applications. We herein review the immunogenicity and immunomodulatory properties of MSCs, their possible mechanisms and potential clinical use for tissue-engineered organ and tissue replacement.

© 2012 The Authors Transplant International © 2012 European Society for Organ Transplantation.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk